© Inserm / Patrick Delapierre
Pier-Vincenzo Piazza, Inserm Grand Prix
The Inserm Grand Prix is awarded to Pier-Vincenzo Piazza, Inserm Research Director and Director of Inserm Unit 862, “Neurocentre Magendie,” for his body of research on the physiopathology of psychiatric illnesses. Both a physician and psychiatrist, Pier-Vincenzo Piazza has devoted himself to experimental psychiatric research in order to develop new treatments for mental disorders.
He recently identified a mechanism that can naturally protect the brain from the harmful effects of cannabis in animals, something that has enabled him and his team to reveal a new class of pharmacological agents and to select the first candidate drug, AEF0117. This drug, which will be tested in clinical trials in 2016, is able to inhibit the behavioural effects of THC. This discovery paves the way for potential treatments for cannabis addiction.
Peter Piot, International Prize
The International Prize is awarded to Peter Piot, a physician specialising in microbiology and former Director of Onusida, in recognition for his body of research on deadly viruses. He jointly discovered Ebola virus in 1976, and has actively worked to combat HIV. As Director of the London School of Hygiene and Tropical Medicine, he is currently involved in researching a vaccine for Ebola virus.
Étienne-Émile Baulieu, Honorary Prize
The Honorary Prize distinguishes Professor Étienne-Émile Baulieu, researcher at Inserm Unit “Steroids, Neuroprotection and Neuroregeneration” (Inserm Unit 1195), for his work on steroid hormones. Recognised throughout the world for having discovered DHEA secretion by the adrenal glands and for having invented the abortion pill, he is currently working on an approach to Alzheimer’s disease.
The Opecst-Inserm Prize is awarded to José-Alain Sahel, ophthalmologist, founder and Director of The Vision Institute (Inserm Unit 968), a pioneer of artificial retina research and regenerative eye treatments.
The Research Prizes are awarded to Caroline Robert, physician and Codirector of the Melanoma Research Team at Inserm Unit 981, for her work on melanoma, and to Archana Singh-Manoux, Inserm Research Director at the “Center for Research in Epidemiology and Population Health” (Inserm Unit 1018), in recognition for her studies on cognitive ageing.
This year, Innovation Prizes honour René Ferrera, an Inserm research engineer at the CarMeN Laboratory (Inserm Unit 1060), whose achievements include the development of new techniques for the protection and evaluation of myocardial viability, and Claire Lissalde, a research engineer and head of Inserm’s audiovisual service (Department of Scientific Information and Communication), for her original work in science outreach.
Gilles Bloch has been appointed Chairman and Chief Executive Officer of the French National Institute of Health and Medical Research (Inserm) by the Council of Ministers. ...
The CNRS and Inserm, in association with the CPU, INED, INRAE and IRD, under the umbrella of ATHENA and AVIESAN1, are joining forces to raise key scientific questions on health and environmental crises and combine the initiatives of the humanities, social sciences ...